 |
Abdera Therapeutics
Last updated: July 31, 2024
CEO Lori Lyons-Williams
Canada | Funding: $148.3M (+)
Website: https://abderatherapeutics.com
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
Website: https://abderatherapeutics.com
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
